EDAP - Edap Tms S.a.
EDAP TMS S. A. , together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Market Cap
- $178.2M
- Beta
- -0.08
- 52-Week Range
- 1.21-5.05
- CEO
- Ryan Rhodes
- Employees
- 289
- IPO Date
- Aug 1, 1997
- Exchange
- NASDAQ
EDAP Options Snapshot
Options pricing data for EDAP is refreshed daily after the close. When listed contracts exist, this page surfaces the latest at-the-money implied volatility, max pain strike, dealer gamma exposure (GEX), and 25-delta skew. Listed contracts and live snapshots appear once the options chain has been published by the exchange for the most recent session.
What This Page Covers
The EDAP overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.